Edinburgh Postnatal Depression Score Calculator
Screen for postnatal depression using the 10-item Edinburgh Postnatal Depression Scale. Enter values for instant results with step-by-step formulas.
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist
Medical disclaimer: This calculator is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Results are general estimates and may not reflect your individual circumstances. Always consult a qualified healthcare professional before making decisions about your health.
Formula
EPDS Total = Sum of 10 Items (each scored 0-3) | Range: 0-30
Each of the 10 questions is scored 0 to 3 based on symptom frequency over the past 7 days. Items 1 and 2 are reverse-scored (positive experiences). A total score of 13 or above indicates probable depression. Question 10 about self-harm requires independent clinical attention regardless of the total score.
Worked Examples
Example 1: High-Risk Postnatal Screening
Problem:A mother 6 weeks postpartum scores: Q1=2, Q2=2, Q3=2, Q4=2, Q5=2, Q6=2, Q7=1, Q8=2, Q9=1, Q10=1.
Solution:Total Score = 2+2+2+2+2+2+1+2+1+1 = 17 Threshold for probable depression: 13 Score 17 > 13: Likely Depression Self-harm item (Q10) = 1: FLAGGED - requires immediate assessment Anxiety subscale (Q3+Q4+Q5) = 6/9 Depression subscale (Q1+Q2+Q7+Q8+Q9) = 8/15 Coping (Q6) = 2/3
Result:EPDS Score: 17/30 | Risk: Likely Depression | Self-Harm: FLAGGED | Urgent clinical assessment recommended
Example 2: Normal Postpartum Adjustment
Problem:A mother 8 weeks postpartum scores: Q1=0, Q2=0, Q3=1, Q4=1, Q5=0, Q6=1, Q7=0, Q8=0, Q9=0, Q10=0.
Solution:Total Score = 0+0+1+1+0+1+0+0+0+0 = 3 Threshold for probable depression: 13 Score 3 < 10: Low Risk Self-harm item (Q10) = 0: No concern Anxiety subscale = 2/9 Depression subscale = 0/15 Coping = 1/3
Result:EPDS Score: 3/30 | Risk: Low | Self-Harm: None | Continue routine screening
Frequently Asked Questions
What is the Edinburgh Postnatal Depression Scale and who developed it?
The Edinburgh Postnatal Depression Scale, commonly abbreviated as EPDS, is a 10-item self-report questionnaire designed to screen for postnatal depression in women who have recently given birth. It was developed in 1987 by John Cox, Jeni Holden, and Ruth Sagovsky at health centers in Edinburgh and Livingston, Scotland. The scale was specifically created because existing depression screening tools contained somatic symptoms like fatigue and appetite changes that overlap with normal postpartum experiences, leading to high false-positive rates. The EPDS focuses on emotional and cognitive symptoms of depression, making it more appropriate for the postnatal period. It has since been validated in over 60 languages and is used worldwide as the standard screening tool for perinatal mental health assessment in both clinical practice and research settings.
How is the EPDS scored and what do the scores mean?
Each of the 10 EPDS items is scored from 0 to 3 based on symptom severity over the past seven days, giving a total score range of 0 to 30. For items 1 and 2, the scoring is reverse-coded because these questions ask about positive experiences, with the most positive response scoring 0 and the least positive scoring 3. The standard clinical cutoff score is 13 or above, which indicates probable depression requiring further diagnostic assessment. Scores between 10 and 12 suggest possible depression and warrant repeat screening within two to four weeks. Scores below 10 are generally considered within the normal range. However, cutoff scores may vary by cultural context and clinical setting. Some practitioners use a lower threshold of 10 for initial screening to maximize sensitivity and minimize missed cases.
When should the EPDS be administered during and after pregnancy?
Current clinical guidelines recommend EPDS screening at multiple time points during the perinatal period. The first screening should ideally occur during pregnancy, typically at the first prenatal visit or during the second trimester, to establish a baseline and identify antenatal depression which affects 10 to 15 percent of pregnant women. Postnatally, screening is recommended at the six-week postnatal check, which corresponds to the peak onset period for postnatal depression. Additional screening at three months and six months postpartum captures later-onset cases. The American College of Obstetricians and Gynecologists recommends screening at least once during the perinatal period, while the UK National Institute for Health and Care Excellence recommends screening at each postnatal contact. The EPDS can be repeated as frequently as every two weeks to monitor symptom progression or treatment response.
What is the significance of question 10 about self-harm thoughts?
Question 10 asks about thoughts of self-harm and requires special clinical attention regardless of the total EPDS score. Any response other than 'Never' on this item should trigger immediate further assessment by a qualified healthcare professional. Even if the total score falls below the clinical threshold, endorsement of self-harm thoughts indicates potential risk that must not be overlooked. In clinical practice, a positive response on question 10 typically triggers a safety assessment including evaluation of suicidal ideation specificity, presence of a plan, access to means, and protective factors. This item has been shown to have good sensitivity for identifying women at risk of self-harm in the postnatal period. Healthcare providers should have clear protocols in place for responding to positive self-harm screens, including same-day mental health referral pathways.
Can the EPDS be used during pregnancy as well as after birth?
Yes, the EPDS has been validated for use during pregnancy as an antenatal depression screening tool, not just postnatally. Several validation studies have confirmed its psychometric properties in pregnant women, with similar sensitivity and specificity as in the postnatal period. Antenatal depression affects approximately 10 to 15 percent of pregnant women and is a strong predictor of postnatal depression. The same cutoff score of 13 is generally used during pregnancy, though some researchers recommend a slightly lower cutoff of 11 or 12 to account for differences in symptom presentation during pregnancy. Screening during pregnancy allows early identification and treatment, which can improve outcomes for both mother and baby. Untreated antenatal depression is associated with preterm birth, low birth weight, and impaired maternal-fetal bonding.
How does the EPDS compare to other depression screening tools?
The EPDS was specifically designed for the perinatal population, giving it important advantages over general depression screeners like the PHQ-9 or Beck Depression Inventory. General tools include somatic items such as sleep disturbance, appetite changes, fatigue, and concentration difficulties that are common normal experiences in pregnancy and postpartum, leading to inflated scores and false positives. The EPDS avoids these confounders by focusing on emotional and cognitive symptoms. Studies comparing the EPDS to the PHQ-9 in perinatal populations show that the EPDS has comparable sensitivity of around 80 to 86 percent but better specificity of 78 to 87 percent because it produces fewer false positives. The PHQ-9 remains useful as a complementary tool for severity assessment once depression is suspected. Some clinics use both the EPDS for screening and the PHQ-9 for monitoring treatment response.
What are the limitations of using the EPDS as a screening tool?
The EPDS is a screening tool, not a diagnostic instrument, meaning a high score alone does not confirm a diagnosis of postnatal depression. Clinical interview and comprehensive assessment by a trained professional are always required to establish a formal diagnosis. The scale may miss certain presentations of depression, particularly in women who minimize their symptoms due to cultural expectations, social desirability bias, or fear of having their baby taken away. The EPDS has reduced sensitivity in some cultural groups where emotional expression norms differ from Western populations. It does not assess bipolar disorder, psychosis, or anxiety disorders as primary conditions, though some anxiety symptoms are captured. Self-report format means accuracy depends on honest responses, and some women may not feel comfortable disclosing symptoms to healthcare providers they do not know well.
What treatment options are available for women who score high on the EPDS?
Women with EPDS scores indicating probable depression have several evidence-based treatment options. Cognitive behavioral therapy, or CBT, has the strongest evidence base for postnatal depression and can be delivered individually, in groups, or through guided self-help programs. Interpersonal therapy focusing on relationship and role transition issues is also highly effective. For moderate to severe depression, antidepressant medication may be recommended. Selective serotonin reuptake inhibitors such as sertraline are commonly prescribed as first-line pharmacotherapy because they have low breast milk transfer and good safety data during breastfeeding. Peer support groups provide valuable social connection and normalization of experiences. Exercise programs, particularly structured group exercise, have demonstrated significant benefits as adjunctive treatment. The choice of treatment depends on symptom severity, patient preference, breastfeeding status, and availability of services.
How common is postnatal depression and what are the risk factors?
Postnatal depression affects approximately 10 to 20 percent of women in the first year after giving birth, making it one of the most common complications of childbirth. Major risk factors include a personal or family history of depression or anxiety, depression or anxiety during pregnancy, lack of social support, relationship difficulties, stressful life events during pregnancy or postpartum, previous pregnancy loss, traumatic birth experience, and infant health problems. Socioeconomic factors including financial stress, young maternal age, and unplanned pregnancy also increase risk. Biological factors include hormonal fluctuations after delivery, sleep deprivation, and thyroid dysfunction. Women with multiple risk factors have a cumulative probability of developing postnatal depression that can exceed 40 percent. Early identification through screening programs like the EPDS allows timely intervention that can significantly improve outcomes for both mother and child.
Can partners and fathers also be screened using the EPDS?
Yes, the EPDS has been adapted and validated for use in partners and fathers, reflecting growing recognition that paternal postnatal depression is a real and significant condition affecting approximately 8 to 10 percent of new fathers. Studies have validated the EPDS in male partners using a lower cutoff score of 10 rather than 13 because men tend to score lower overall on the scale and may express depression differently. Paternal depression often presents with irritability, anger, social withdrawal, and increased alcohol use rather than the sadness and crying more commonly reported by mothers. The timing of screening for fathers may differ, with peak onset typically occurring 3 to 6 months postpartum rather than the earlier peak seen in mothers. Untreated paternal depression negatively impacts the partner relationship, father-infant bonding, and child behavioral development, making screening of both parents important for whole-family well-being.
References
Background & Theory
History
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist ยท Editorial policy
Related Calculators
๐งฎMadrs Depression Score Calculator
Score depression severity using the Montgomery-Asberg Depression Rating Scale.
๐งฎChads2 Score Calculator
Calculate the CHADS2 stroke risk score for patients with non-valvular atrial fibrillation.
๐งฎCha2ds2-Vasc Score Calculator
Calculate CHA2DS2-VASc score for stroke risk stratification in atrial fibrillation patients.
๐งฎHas-Bled Score Calculator
Assess bleeding risk in patients on anticoagulation using the HAS-BLED scoring system.
๐งฎHEART Score Calculator for Chest Pain Risk
Risk-stratify emergency department patients with chest pain using the HEART score.
๐งฎTIMI Risk Score Calculator
Calculate the TIMI risk score for STEMI and UA/NSTEMI patients.
๐งฎWells Score Dvt Calculator
Estimate pre-test probability of deep vein thrombosis using the Wells clinical criteria.
๐งฎWells Score PE Calculator
Estimate pre-test probability of pulmonary embolism using the Wells criteria.